Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia

Cancer Chemother Rep. Nov-Dec 1973;57(4):485-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Cytarabine / adverse effects
  • Cytarabine / therapeutic use*
  • Daunorubicin / adverse effects
  • Daunorubicin / therapeutic use*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leukemia / drug therapy*
  • Male
  • Middle Aged
  • Remission, Spontaneous

Substances

  • Cytarabine
  • Daunorubicin